Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A T-cell receptor recognizing OVA-peptide/MHC complex is a heterodimeric cell surface receptor expressed on T-lymphocytes that binds with high specificity to a defined peptide epitope derived from ovalbumin, presented on the surface of cells by a major histocompatibility complex (MHC; either class I or II, depending on peptide and system)[3][7][2][1][6]. Binding of this pMHC ligand induces intracellular signaling and T-cell activation, making this system a classical model in immunology for dissecting antigen-specific T-cell responses, affinity/kinetics, tolerance, and cross-reactivity[3][7][4][2]. The most studied forms are the OT-I TCR (CD8+, SIINFEKL/H-2K^b^, MHC I) and DO11.10 TCR (CD4+, OVA 323–339/I-A^d^, MHC II), which provide powerful tools for adoptive T-cell transfer, vaccination, and basic immunological research in mice[2][6][1]. This is not a single universal receptor, but a functional description of TCRs specific for OVA-derived peptide/MHC complexes. If you require information on a specific TCR clone, such as OT-I (class I) vs. DO11.10 (class II), more details can be provided for that exact target.
Recognition of antigenic OVA peptide in the context of MHC leading to T-cell activation - Downstream signaling through CD3 complex upon pMHC binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing ovalbumin peptide–major histocompatibility complex (TCR (OVA-specific), OT-I TCR or DO11.10 TCR (if specifying canonical mouse models)).